AR093527A1 - 6-((S)-1-1-[5-(2-HIDROXI-ETOXI)-PIRIDIN-2-IL]1H-PIRAZOL-3-IL-ETIL)-3H-1,3-BENZOTIAZOL-2-ONA COMO UN ANTAGONISTA DEL RECEPTOR AMPA DEPENDIENTE DE TARP-g 8 - Google Patents

6-((S)-1-1-[5-(2-HIDROXI-ETOXI)-PIRIDIN-2-IL]1H-PIRAZOL-3-IL-ETIL)-3H-1,3-BENZOTIAZOL-2-ONA COMO UN ANTAGONISTA DEL RECEPTOR AMPA DEPENDIENTE DE TARP-g 8

Info

Publication number
AR093527A1
AR093527A1 ARP130104242A ARP130104242A AR093527A1 AR 093527 A1 AR093527 A1 AR 093527A1 AR P130104242 A ARP130104242 A AR P130104242A AR P130104242 A ARP130104242 A AR P130104242A AR 093527 A1 AR093527 A1 AR 093527A1
Authority
AR
Argentina
Prior art keywords
ampa
benzotiazol
etoxi
hidroxi
piridin
Prior art date
Application number
ARP130104242A
Other languages
English (en)
Spanish (es)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of AR093527A1 publication Critical patent/AR093527A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP130104242A 2012-11-27 2013-11-18 6-((S)-1-1-[5-(2-HIDROXI-ETOXI)-PIRIDIN-2-IL]1H-PIRAZOL-3-IL-ETIL)-3H-1,3-BENZOTIAZOL-2-ONA COMO UN ANTAGONISTA DEL RECEPTOR AMPA DEPENDIENTE DE TARP-g 8 AR093527A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261730273P 2012-11-27 2012-11-27

Publications (1)

Publication Number Publication Date
AR093527A1 true AR093527A1 (es) 2015-06-10

Family

ID=49753484

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130104242A AR093527A1 (es) 2012-11-27 2013-11-18 6-((S)-1-1-[5-(2-HIDROXI-ETOXI)-PIRIDIN-2-IL]1H-PIRAZOL-3-IL-ETIL)-3H-1,3-BENZOTIAZOL-2-ONA COMO UN ANTAGONISTA DEL RECEPTOR AMPA DEPENDIENTE DE TARP-g 8

Country Status (35)

Country Link
US (1) US8765960B2 (OSRAM)
EP (1) EP2925754B1 (OSRAM)
JP (1) JP6246227B2 (OSRAM)
KR (1) KR101693133B1 (OSRAM)
CN (1) CN104797578B (OSRAM)
AP (1) AP2015008489A0 (OSRAM)
AR (1) AR093527A1 (OSRAM)
AU (1) AU2013352594B2 (OSRAM)
BR (1) BR112015011200A2 (OSRAM)
CA (1) CA2889243C (OSRAM)
CL (1) CL2015001419A1 (OSRAM)
CR (1) CR20150267A (OSRAM)
CY (1) CY1118657T1 (OSRAM)
DK (1) DK2925754T3 (OSRAM)
DO (1) DOP2015000113A (OSRAM)
EA (1) EA026686B1 (OSRAM)
ES (1) ES2618260T3 (OSRAM)
HR (1) HRP20170274T1 (OSRAM)
HU (1) HUE033447T2 (OSRAM)
IL (1) IL238831B (OSRAM)
JO (1) JO3225B1 (OSRAM)
MA (1) MA38126B1 (OSRAM)
MX (1) MX356478B (OSRAM)
MY (1) MY177721A (OSRAM)
PE (1) PE20151728A1 (OSRAM)
PH (1) PH12015501154B1 (OSRAM)
PL (1) PL2925754T3 (OSRAM)
PT (1) PT2925754T (OSRAM)
SG (1) SG11201504164VA (OSRAM)
SI (1) SI2925754T1 (OSRAM)
TN (1) TN2015000200A1 (OSRAM)
TW (2) TW201825484A (OSRAM)
UA (1) UA114345C2 (OSRAM)
WO (1) WO2014085153A1 (OSRAM)
ZA (1) ZA201503733B (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201609719A (zh) * 2014-05-28 2016-03-16 美國禮來大藥廠 作為TARP-γ8依賴性AMPA受體拮抗劑之6-經取代-3H-1,3-苯并噻唑-2-酮化合物
AU2016255424B2 (en) * 2015-04-29 2020-10-08 Janssen Pharmaceutica Nv Benzimidazolone and benzothiazolone compounds and their use as AMPA receptor modulators
ES2759348T3 (es) 2015-04-29 2020-05-08 Janssen Pharmaceutica Nv Imidazopirazinas y pirazolopirimidinas y su utilización como moduladores de receptores AMPA
ES2865330T3 (es) 2015-04-29 2021-10-15 Janssen Pharmaceutica Nv Azabenzimidazoles y su uso como moduladores del receptor AMPA
ES2767707T3 (es) 2015-04-29 2020-06-18 Janssen Pharmaceutica Nv Compuestos de indolona y su uso como moduladores de receptor AMPA
AU2017350689B2 (en) * 2016-10-26 2021-05-20 Rapport Therapeutics, Inc. Fused bicylic pyridine compounds and their use as AMPA receptor modulators
RU2650523C1 (ru) 2017-07-24 2018-04-16 федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) Производное пиридоксина для лечения эпилепсии
RU2703286C1 (ru) * 2019-06-18 2019-10-16 федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) Соли (5-гидрокси-3,4-бис(гидроксиметил)-6-метилпиридин-2-ил)метансульфокислоты и способ их получения

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY132385A (en) * 1995-08-31 2007-10-31 Novartis Ag 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives
JP2000281676A (ja) * 1999-01-25 2000-10-10 Yamanouchi Pharmaceut Co Ltd Ampa拮抗化合物の新規製造法
KR100850728B1 (ko) * 2000-06-12 2008-08-06 에자이 알앤드디 매니지먼트 가부시키가이샤 1,2-디하이드로피리딘 화합물, 그의 제조 방법 및 그의 용도
US8995993B2 (en) * 2000-10-11 2015-03-31 Gogo Llc System for managing mobile internet protocol addresses in an airborne wireless cellular network
DE602005009021D1 (de) * 2004-12-17 2008-09-25 Lilly Co Eli Neue mch-rezeptorantagonisten
WO2007076161A2 (en) 2005-12-27 2007-07-05 Myriad Genetics, Inc Compounds with therapeutic activity
TW200817385A (en) * 2006-07-04 2008-04-16 Organon Nv Heterocyclic derivatives
WO2010041162A1 (en) * 2008-10-08 2010-04-15 Pfizer Inc. Tetrahydrofuranyl sulfonamides for use as ampa modulators in the treatment of cns disorders
NZ593473A (en) * 2009-01-12 2013-02-22 Pfizer Ltd Sulfonamide derivatives
CN102985420B (zh) * 2010-06-01 2017-07-04 安吉翁生物医药有限公司 细胞色素p450抑制剂及其用途
US9527807B2 (en) * 2011-04-05 2016-12-27 Takeda Pharmaceutical Company Limited Sulfonamide derivative and use thereof
TW201609719A (zh) 2014-05-28 2016-03-16 美國禮來大藥廠 作為TARP-γ8依賴性AMPA受體拮抗劑之6-經取代-3H-1,3-苯并噻唑-2-酮化合物

Also Published As

Publication number Publication date
US8765960B2 (en) 2014-07-01
CN104797578A (zh) 2015-07-22
EP2925754B1 (en) 2016-12-28
BR112015011200A2 (pt) 2017-07-11
UA114345C2 (uk) 2017-05-25
KR101693133B1 (ko) 2017-01-04
CY1118657T1 (el) 2017-07-12
HRP20170274T1 (hr) 2017-04-07
ZA201503733B (en) 2017-09-27
MA38126B1 (fr) 2017-11-30
TW201434834A (zh) 2014-09-16
PH12015501154A1 (en) 2015-08-10
AU2013352594B2 (en) 2016-02-18
AU2013352594A1 (en) 2015-06-04
HK1209116A1 (en) 2016-03-24
SG11201504164VA (en) 2015-07-30
CA2889243A1 (en) 2014-06-05
PE20151728A1 (es) 2015-12-02
JO3225B1 (ar) 2018-03-08
DK2925754T3 (en) 2017-02-20
CN104797578B (zh) 2016-11-23
CR20150267A (es) 2015-09-16
IL238831B (en) 2018-08-30
DOP2015000113A (es) 2015-06-15
ES2618260T3 (es) 2017-06-21
MY177721A (en) 2020-09-23
EA026686B1 (ru) 2017-05-31
MX356478B (es) 2018-05-30
TW201825484A (zh) 2018-07-16
CL2015001419A1 (es) 2015-10-02
SI2925754T1 (sl) 2017-02-28
WO2014085153A1 (en) 2014-06-05
TWI618705B (zh) 2018-03-21
IL238831A0 (en) 2015-06-30
PH12015501154B1 (en) 2018-05-30
AP2015008489A0 (en) 2015-05-31
MX2015006697A (es) 2015-08-05
US20140148441A1 (en) 2014-05-29
PL2925754T3 (pl) 2017-07-31
WO2014085153A8 (en) 2014-07-31
JP6246227B2 (ja) 2017-12-13
EP2925754A1 (en) 2015-10-07
EA201590823A1 (ru) 2015-08-31
MA38126A1 (fr) 2017-03-31
JP2016501219A (ja) 2016-01-18
TN2015000200A1 (en) 2016-10-03
KR20150070401A (ko) 2015-06-24
CA2889243C (en) 2017-06-13
HUE033447T2 (en) 2017-11-28
PT2925754T (pt) 2017-02-27

Similar Documents

Publication Publication Date Title
AR093527A1 (es) 6-((S)-1-1-[5-(2-HIDROXI-ETOXI)-PIRIDIN-2-IL]1H-PIRAZOL-3-IL-ETIL)-3H-1,3-BENZOTIAZOL-2-ONA COMO UN ANTAGONISTA DEL RECEPTOR AMPA DEPENDIENTE DE TARP-g 8
UY34778A (es) ?COMPUESTOS DE HEXAHIDROPIRANO[3,4-d][1,3]TIAZIN-2-AMINA HETEROCÍCLICOS SUSTITUÍDOS?.
MX378288B (es) Inhibidores de pirimidina del fgfr4.
UY34261A (es) Compuestos fungicidas de 1-{2-[2-halo-4-(4-halogen-fenoxi)-fenil]-2-alcoxi-2-ciclil-etil}-1h-[1,2,4]triazol sustituidos
GT201200332A (es) Composiciones sòlidas
UY34302A (es) COMPUESTOS DE HEXAHIDROPIRANO[3,4-d][1,3]TIAZIN-2- AMINA
MX2019010446A (es) Compuestos de anillos fusionados biciclicos derivados de piridilo como inhibidores de fgfr4.
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
EA201501142A1 (ru) Гетероциклические соединения в качестве средств для борьбы с вредителями
UY34472A (es) Derivados modificados de 4-fenil-piridina
EP2681216A4 (en) SUBSTITUTED 6.5-CONDENSED BICYCLIC HETEROARYL COMPOUNDS
PH12015502546B1 (en) 3-(4-isobutyl-2-methylphenyl) propanal as perfume ingredient
LT3483163T (lt) Triazol[4,5-d]pirimidino dariniai kaip cb2 receptorių antagonistai
UY34863A (es) Antagonistas de iap
CL2014003123A1 (es) 5-amino [1,4], tiazinas como inhibidores de bace1; uso del compuesto contra la enfermedad de alzheimer.
MX372740B (es) Derivado de 2,4-diaminopirimidina biciclico fusionado como un inhibidor dual de alk y fak.
UY34629A (es) Inhibidores de pirazolopirimidinilo de enzima activadora de ubicuitina
MX373855B (es) Derivados de pirrolo[2,3-d]pirimidina como agonistas del receptor de canabinoides 2 (cb2).
UY33976A (es) Derivados de pirazolo-pirimidina.
EA201790939A1 (ru) ТРИАЗОЛО[4,5-d]ПИРИМИДИНЫ В КАЧЕСТВЕ АГОНИСТОВ КАННАБИНОИДНЫХ РЕЦЕПТОРОВ ТИПА 2
CL2015002358A1 (es) Compuestos bicíclicos.
IN2014DN06964A (OSRAM)
PH12015501146A1 (en) Hydantoin derivative
UY34072A (es) Derivados sustituidos de indol
AR092772A1 (es) Derivado de 7-azaindol

Legal Events

Date Code Title Description
FB Suspension of granting procedure